DAVA compared with BDTX: revenue, margins and what each company keeps, and the suppliers and customers both name

DAVAEndava plc

Mkt capRevenueRevenue

BDTXBlack Diamond Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

DAVAEndava plc

BDTXBlack Diamond Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

DAVA1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Oct 28 '26thin chain±41.2%▼−12.24%×0.30

BDTX1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±27.6%▲+7.26%×0.26

= impliedDAVA realized, solidBDTX realized, hatchedOne scale, both sides: full bar = 42%× = |realized| ÷ impliedSource: market data

DAVAEndava plc

1.76▲+4.47%· post 1.76

Mkt cap$196.7MRevenue—

BDTXBlack Diamond Therapeutics, Inc.

1.74▲+4.61%· post 1.74

ClosedNov 6 '26

Mkt cap$99.7MRevenue$70MQ1 FY25

Compare

ClosedNov 6 '26

DAVAEndava plc

BDTXBlack Diamond Therapeutics, Inc.

1.76▲+4.47%post 1.76

Price

1.74▲+4.61%post 1.74

$196.7M

Mkt cap

$99.7M

—

Revenue

$70MQ1 FY25

DAVA1.76▲+4.47%vsBDTX1.74▲+4.61%ClosedNov 6 '26